Accelerate antiviral discovery with structure-guided antigen modeling, antibody design, docking, molecular dynamics simulation, and developability assessment.
Hantaviruses are zoonotic pathogens that can cause severe diseases in humans, including hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). The lack of approved antivirals or licensed vaccines highlights the urgent need for innovative therapeutics and diagnostics.
The Gn and Gc envelope glycoproteins mediate host cell receptor binding and membrane fusion, making them principal targets for neutralizing antibodies. The nucleoprotein (NP) is highly conserved and critical for viral replication, serving as a valuable target for diagnostic and therapeutic strategies.

Prefusion complex of Gn and Gc forms viral spikes mediating receptor binding and entry.

Receptor-binding head domain on Gn, a key target for neutralizing antibodies.

Responsible for membrane fusion, contains conserved regions for antibody targeting.

Highly conserved internal protein; essential for replication and diagnostic applications.
Define targets, goals, and project scope.
Modeling, refinement, and validation.
Structure prediction or de novo design & optimization.
Antibody-antigen docking and pose selection.
Stability assessment and trajectory analysis.
Physicochemical properties and liability analysis.
Comprehensive report and ranked candidate recommendations.
Tailored to your targets and therapeutic or diagnostic goals.
Capture complex conformational epitopes accurately.
Advanced docking for high-confidence complex prediction.
In-depth dynamics analysis for realistic binding assessment.
Quantitative affinity estimation to prioritize best candidates.
Experienced scientists provide actionable insights and guidance.
Antigen Structure Model
Antibody Structure Model
Docked Complexes
Epitope Map
Interaction Network
MD Report
Binding Free-Energy Results
Developability Report
Candidate Ranking
Final Technical Report
Discover and optimize potent neutralizing antibodies.
Design cross-reactive antibodies against diverse strains.
Develop high-sensitivity and high-specificity diagnostic reagents.
Evaluate immunogen designs for improved antigenicity.
Design combinations to enhance coverage and prevent escape.
Assess variants and predict potential escape mutations.
We model key targets including Gn/Gc glycoprotein complex, Gn head domain, Gc fusion glycoprotein, and nucleoprotein (NP).
Yes. We perform all-atom MD simulations and free-energy calculations to evaluate stability and binding affinity.
Yes. We use advanced computational methods and AI-guided design to generate and optimize novel antibody candidates.
You will receive comprehensive modeling results, analysis reports, and ranked antibody or antigen candidate recommendations.
Our computational expertise can accelerate your path from target to candidate.
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk